Abstract:
Bioprosthetic valve thrombosis is a growing recognized entity,
especially with the increasing use of the valve in vale procedures and
the advent of new detection technologies (e.g., 4D CT and 4D
echocardiography). However, the optimal management strategy in the acute
context is not established. This paper presents a case of early
thrombosis following the percutaneous tricuspid valve in vale procedure
that was successfully managed with thrombolysis.
Keywords: bioprosthetic valve thrombosis, percutaneous valve in valve
procedure, fibrinolysis, transesophageal echocardiography
Introduction:
Bioprosthetic Valves are generally considered to be less thrombogenic
than mechanical valves. With an increased attitude for transcatheter
heart valve implantation, which precludes high-risk cardiac
reoperations, and evolving use of 4D echocardiography and computed
tomography, the prevalence and recognition of bioprosthetic valve
thrombosis(BPVT) are increasing. Prevention and optimal management of
this condition, particularly in an acute setting, has not been fully
elucidated. Herein we present a case of early thrombosis following
transcatheter tricuspid valve in valve implantation that was favorably
managed by thrombolysis.